echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Hypertension: Predictive value of pulmonary arterial compliance in patients with systemic lupus erythematosus combined with pulmonary hypertension.

    Hypertension: Predictive value of pulmonary arterial compliance in patients with systemic lupus erythematosus combined with pulmonary hypertension.

    • Last Update: 2020-09-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pulmonary hypertension is a serious complication of systemic lupus erythematosus, characterized by increased load after the right chamber, including pulmonary arterial compliance (PAC) and pulmonary vascular resistance.
    role of THE PAC in predicting the prognosis of pulmonary hypertension associated with systemic lupus erythematosus is not yet clear.
    a recent study published in Hypertension, a leading journal of cardiovascular medicine, looked at 120 patients diagnosed with systemic lupus-related pulmonary hypertension between February 2012 and December 2016.
    the researchers analyzed the subjects' baseline clinical characteristics and hemodynamic parameters.
    the baseline right post-astral load is layered according to PAC and pulmonary vascular resistance.
    end of the study was a combination of mortality and clinical deterioration.
    15 months (8.5-24.0), 49 (41%) subjects had an end event.
    patients with PAC-lt;1.39 mL/mmHg had a 3.09 times higher risk of end-point events than those with a PAC of 1.39 mL/mmHg (95% CI was 1.54-6.20, P-0.001).
    multivariable Cox regression analysis showed that the strated right post-astric load was the only independent predictor of the study endpoint (risk ratio was 2.009 (95% CI was 1.390-2.904) and P.lt;0.001).
    patients with the highest post-right post-cardiotreloyny load (PAC.lt;1.39 mL/mmHg, pulmonary vascular resistance of 10.3 Wood units) had the highest risk of developing a study endpoint (2 x 6.10; P.lt;0.014).
    results of this study show that PAC is a good predictor of mortality and clinical deterioration in patients with systemic lupus-related pulmonary hypertension.
    in addition to pulmonary vascular resistance, PACs may be an effective tool for screening high-risk groups in these patients.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.